Indian Vaccine Covaxin grabs global attention, says ICMR

According to the Indian Council of Medical Research the vaccine developed by Indian pharmaceutical company Bharat Biotech, Covaxin has gained popularity and attention from all over the world. The vaccine is studied to be impressively safe and is currently ongoing its Phase III Clinical Trials in 22 locations across India. The results from the first two clinical trials have been very positive.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy